» Articles » PMID: 19142824

Outcomes of a Peer HIV Prevention Program with Injection Drug and Crack Users: the Risk Avoidance Partnership

Overview
Publisher Informa Healthcare
Date 2009 Jan 15
PMID 19142824
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The Risk Avoidance Partnership (RAP) Project conducted in Hartford, Connecticut, tested a program to train active drug injectors and crack cocaine users as "Peer Health Advocates" (PHAs) to deliver a modular HIV, hepatitis, and STI prevention intervention to hard-to-reach drug users in their networks and others in the city. The intervention was designed to diffuse health promotion and risk-reduction interventions by supporting PHAs to model prevention practices and deliver risk- and harm-reduction materials and information. We compared change in behaviors and attitudes between baseline and 6-month follow-up of 112 primarily African-American and Latino PHAs, 223 of their drug-user network contact referrals, and 118 other study recruits (total n = 523). Results indicated significant HIV risk reduction among all study participants, associated with significant health advocacy action conducted by PHAs, and a relationship between exposure to the RAP peer-delivered intervention and risk reduction among all study groups. Findings suggest that active drug users' engagement in peer health advocacy can set in motion a feedback and diffusion process that supports both the continued work of the PHAs and the adoption of harm reduction and mimicking of health advocacy by their peers.

Citing Articles

Differences in characteristics and interactions with close contacts among PWID in the San Diego Border Region before and during the COVID-19 pandemic.

Marquez L, Martin N, Strathdee S, Skaathun B J Migr Health. 2024; 10:100267.

PMID: 39403696 PMC: 11471669. DOI: 10.1016/j.jmh.2024.100267.


Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.

Buchanan A, Katenka N, Lee Y, Wu J, Pantavou K, Friedman S Pathogens. 2023; 12(2).

PMID: 36839598 PMC: 9967280. DOI: 10.3390/pathogens12020326.


Toward Community Empowerment: The Puerto Rican .

Gelpi-Acosta C, Guarino H, Benoit E, Deren S, Rodriguez A Contemp Drug Probl. 2022; 48(1):38-57.

PMID: 36061616 PMC: 9435813. DOI: 10.1177/0091450920964576.


Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs.

Aroke H, Buchanan A, Katenka N, Crawford F, Lee T, Halloran M AIDS Behav. 2022; 27(2):578-590.

PMID: 35932359 PMC: 10408304. DOI: 10.1007/s10461-022-03792-5.


Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.

Oguya F, Kenya P, Ongecha F, Mureithi P, Musyoka H, Muraguri N BMC Public Health. 2021; 21(1):1549.

PMID: 34391389 PMC: 8364050. DOI: 10.1186/s12889-021-11373-9.


References
1.
Ramirez-Valles J . The protective effects of community involvement for HIV risk behavior: a conceptual framework. Health Educ Res. 2002; 17(4):389-403. DOI: 10.1093/her/17.4.389. View

2.
Latkin C . Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Rep. 1998; 113 Suppl 1:151-9. PMC: 1307737. View

3.
Sikkema K, Anderson E, Kelly J, Winett R, Gore-Felton C, Roffman R . Outcomes of a randomized, controlled community-level HIV prevention intervention for adolescents in low-income housing developments. AIDS. 2005; 19(14):1509-16. DOI: 10.1097/01.aids.0000183128.39701.34. View

4.
Latkin C, Hua W, Davey M . Factors associated with peer HIV prevention outreach in drug-using communities. AIDS Educ Prev. 2004; 16(6):499-508. DOI: 10.1521/aeap.16.6.499.53794. View

5.
Wood E, Kerr T, Spittal P, Small W, Tyndall M, OShaughnessy M . An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health. 2003; 80(3):455-64. PMC: 3455981. DOI: 10.1093/jurban/jtg052. View